Biomea Fusion, Inc. (BMEA) stock
BMEANasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.56−0.05 (-7.89%)
Close on Nov 12, 2026Market cap $40.79MP/E –Yield –
Biomea Fusion total assets
Total assets on the balance sheet at the end of each period.
Biomea Fusion's total assets was $28.10M at Sep 30, 2026. For fiscal 2025 it was $58.57M, down 26.7% from the year before. The highest annual figure on record is $199.93M in fiscal 2023.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $58.57M | -26.7% |
| FY2024 | Dec 31, 2024 | $79.94M | -60.0% |
| FY2023 | Dec 31, 2023 | $199.93M | +54.6% |
| FY2022 | Dec 31, 2022 | $129.31M | -30.4% |
| FY2021 | Dec 31, 2021 | $185.71M | +197.0% |
| FY2020 | Dec 31, 2020 | $62.53M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $28.10M | -49.1% |
| Q2 FY2026 | Jun 30, 2026 | $36.87M | -49.6% |
| Q1 FY2026 | Mar 31, 2026 | $46.39M | -15.7% |
| Q4 FY2025 | Dec 31, 2025 | $58.57M | -26.7% |
| Q3 FY2025 | Sep 30, 2025 | $55.19M | -50.0% |
| Q2 FY2025 | Jun 30, 2025 | $73.16M | -46.3% |
| Q1 FY2025 | Mar 31, 2025 | $55.06M | -67.3% |
| Q4 FY2024 | Dec 31, 2024 | $79.94M | -60.0% |
| Q3 FY2024 | Sep 30, 2024 | $110.42M | -50.9% |
| Q2 FY2024 | Jun 30, 2024 | $136.16M | -45.2% |
| Q1 FY2024 | Mar 31, 2024 | $168.49M | +49.6% |
| Q4 FY2023 | Dec 31, 2023 | $199.93M | +54.6% |
| Q3 FY2023 | Sep 30, 2023 | $225.09M | +55.2% |
| Q2 FY2023 | Jun 30, 2023 | $248.67M | +53.8% |
| Q1 FY2023 | Mar 31, 2023 | $112.64M | -35.6% |
| Q4 FY2022 | Dec 31, 2022 | $129.31M | -30.4% |
| Q3 FY2022 | Sep 30, 2022 | $145.05M | -27.3% |
| Q2 FY2022 | Jun 30, 2022 | $161.74M | -22.8% |
| Q1 FY2022 | Mar 31, 2022 | $174.86M | +192.0% |
| Q4 FY2021 | Dec 31, 2021 | $185.71M | +197.0% |
| Q3 FY2021 | Sep 30, 2021 | $199.40M | – |
| Q2 FY2021 | Jun 30, 2021 | $209.53M | – |
| Q1 FY2021 | Mar 31, 2021 | $59.88M | – |
| Q4 FY2020 | Dec 31, 2020 | $62.53M | – |
See a number that looks wrong?